Diabetes & CV Disease
Sort by:
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium
Diabetocardiology: A New Subspecialty
FEATURING
Eugene Braunwald
- 1,145 views
- January 11, 2019
- 10
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3
FEATURING
James Gavin Iii
- 647 views
- November 30, 2023
- 10
Canadian Collaborative Research Network
Chronic Kidney Disease: New Treatments to Improve Outcomes
FEATURING
Louise Moist
- 1,528 views
- July 26, 2023
- 10
ACC 2022 Conference Coverage
ACC 2022: SGLT2i in Heart Failure - HFrEF, HFpEF, Class Effect?
FEATURING
Stephen Greene
- 1,448 views
- April 12, 2022
- 10
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,151 views
- December 3, 2017
- 8
The Texas Heart Institute
Updates in Guidelines for the Management of Chronic Coronary Artery Disease: What We Should Pay Closer Attention To
FEATURING
Salim Virani
- 870 views
- March 15, 2024
- 10
ASPC 2019 Congress on CVD Prevention
Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes
FEATURING
Robert Chilton
- 1,410 views
- August 9, 2019
- 10
Mount Sinai Advanced Innovations in Heart Failure
Heart Failure With Preserved Ejection Fraction: Role of SGLT2 Inhibitors
FEATURING
Juan Badimon
- 946 views
- March 2, 2022
- 10
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,785 views
- February 7, 2022
- 9
Cleveland Clinic Endocrinology & Metabolism Institute
The Challenge of Hypertriglyceridemia
FEATURING
Michelle Lundholm
- 1,780 views
- January 27, 2022
- 10
ACC 2024 Insights
ACC 2024 Insights: Prescribing Medications for Obesity Management in Young Adults
FEATURING
Michael Honigberg
- 980 views
- April 11, 2024
- 9
Practical Ways to Achieve Targets in Diabetes Care
Adjunctive Therapies in Type 1 Diabetes: Anything Useful Besides Insulin
FEATURING
John Buse
- 964 views
- July 31, 2023
- 9
ACC 2022 Conference Coverage
ACC 2022: An Overview of SGLT2i and GLP1 RA Use in Cardiovascular Disease
FEATURING
Robert Eckel
- 1,561 views
- May 24, 2022
- 9
4th National Congress on Prevention of Diabetes and Its Complications
Vitamin D and Diabetes Prevention: Results of the D2D Study
FEATURING
Mary Rhee
- 3,582 views
- March 23, 2020
- 9
ACC 2023 Conference Coverage
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
FEATURING
Barry Borlaug
- 1,317 views
- March 15, 2023
- 9
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
FEATURING
Derek LeRoith
- 2,239 views
- June 16, 2017
- 8
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors - Clinical Questions for HFpEF That Are Yet to Be Answered Back to the Lab
FEATURING
Joseph Hill
- 634 views
- November 23, 2023
- 8
St. Louis Shock & Heart Failure Symposium 2022
Heart Failure Therapy: Focus on Guidelines
FEATURING
Justin Vader
- 1,140 views
- January 9, 2023
- 9
Scripps Health
Kidney Disease Management: Diagnosis, CKD Indicators, Key Management Elements, KDIGO Guidelines and Pharmacological Options
FEATURING
Andrew J. King
- 1,374 views
- August 25, 2021
- 8